These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 12135369

  • 21. Adamalysins. A family of metzincins including TNF-alpha converting enzyme (TACE).
    Killar L, White J, Black R, Peschon J.
    Ann N Y Acad Sci; 1999 Jun 30; 878():442-52. PubMed ID: 10415747
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Relaxed specificity of matrix metalloproteinases (MMPS) and TIMP insensitivity of tumor necrosis factor-alpha (TNF-alpha) production suggest the major TNF-alpha converting enzyme is not an MMP.
    Black RA, Durie FH, Otten-Evans C, Miller R, Slack JL, Lynch DH, Castner B, Mohler KM, Gerhart M, Johnson RS, Itoh Y, Okada Y, Nagase H.
    Biochem Biophys Res Commun; 1996 Aug 14; 225(2):400-5. PubMed ID: 8753775
    [Abstract] [Full Text] [Related]

  • 24. TACE/ADAM-17 enzymatic activity is increased in response to cellular stimulation.
    Doedens JR, Mahimkar RM, Black RA.
    Biochem Biophys Res Commun; 2003 Aug 22; 308(2):331-8. PubMed ID: 12901873
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3.
    Amour A, Slocombe PM, Webster A, Butler M, Knight CG, Smith BJ, Stephens PE, Shelley C, Hutton M, Knäuper V, Docherty AJ, Murphy G.
    FEBS Lett; 1998 Sep 11; 435(1):39-44. PubMed ID: 9755855
    [Abstract] [Full Text] [Related]

  • 27. Reactive oxygen species mediate tumor necrosis factor alpha-converting, enzyme-dependent ectodomain shedding induced by phorbol myristate acetate.
    Zhang Z, Oliver P, Lancaster JR, Schwarzenberger PO, Joshi MS, Cork J, Kolls JK.
    FASEB J; 2001 Feb 11; 15(2):303-5. PubMed ID: 11156944
    [Abstract] [Full Text] [Related]

  • 28. Definition of peptide inhibitors from a synthetic peptide library by targeting gelatinase B/matrix metalloproteinase-9 (MMP-9) and TNF-α converting enzyme (TACE/ADAM-17).
    Qiu Z, Yan M, Li Q, Liu D, Van den Steen PE, Wang M, Opdenakker G, Hu J.
    J Enzyme Inhib Med Chem; 2012 Aug 11; 27(4):533-40. PubMed ID: 21827363
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1.
    Canault M, Leroyer AS, Peiretti F, Lesèche G, Tedgui A, Bonardo B, Alessi MC, Boulanger CM, Nalbone G.
    Am J Pathol; 2007 Nov 11; 171(5):1713-23. PubMed ID: 17872973
    [Abstract] [Full Text] [Related]

  • 34. Design and characterization of a fluorogenic substrate selectively hydrolyzed by stromelysin 1 (matrix metalloproteinase-3).
    Nagase H, Fields CG, Fields GB.
    J Biol Chem; 1994 Aug 19; 269(33):20952-7. PubMed ID: 8063713
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Inhibition of the tumor necrosis factor-alpha-converting enzyme by its pro domain.
    Gonzales PE, Solomon A, Miller AB, Leesnitzer MA, Sagi I, Milla ME.
    J Biol Chem; 2004 Jul 23; 279(30):31638-45. PubMed ID: 15100227
    [Abstract] [Full Text] [Related]

  • 37. Release of TNF-alpha during myocardial reperfusion depends on oxidative stress and is prevented by mast cell stabilizers.
    Gilles S, Zahler S, Welsch U, Sommerhoff CP, Becker BF.
    Cardiovasc Res; 2003 Dec 01; 60(3):608-16. PubMed ID: 14659806
    [Abstract] [Full Text] [Related]

  • 38. Specific sequence elements are required for the expression of functional tumor necrosis factor-alpha-converting enzyme (TACE).
    Milla ME, Leesnitzer MA, Moss ML, Clay WC, Carter HL, Miller AB, Su JL, Lambert MH, Willard DH, Sheeley DM, Kost TA, Burkhart W, Moyer M, Blackburn RK, Pahel GL, Mitchell JL, Hoffman CR, Becherer JD.
    J Biol Chem; 1999 Oct 22; 274(43):30563-70. PubMed ID: 10521439
    [Abstract] [Full Text] [Related]

  • 39. Delineating the molecular basis of the inactivity of tissue inhibitor of metalloproteinase-2 against tumor necrosis factor-alpha-converting enzyme.
    Lee MH, Rapti M, Murphy G.
    J Biol Chem; 2004 Oct 22; 279(43):45121-9. PubMed ID: 15308656
    [Abstract] [Full Text] [Related]

  • 40. Phage display of functional human TNF-alpha converting enzyme catalytic domain: a rapid method for the production of stabilized proteolytic proteins for assay development and high-throughput screening.
    Chen Y, Diener K, Patel IR, Kawooya JK, Martin GA, Yamdagni P, Zhang X, Sandrasalphaa A, Sahasrabudhe S, Busch SJ.
    J Biomol Screen; 2002 Oct 22; 7(5):433-40. PubMed ID: 14599359
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.